MedTrace Logo

Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases

NCT02479568 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2022-02-28

No results posted yet for this study

Summary

The primary aim is to examine both the acute and chronic effects of hesperidin consumption from 100% Florida orange juice in various doses on functional and systemic markers associated with cardiovascular disease (CVD) risks.

Conditions

  • Cardiovascular Risk Factors

Interventions

DIETARY_SUPPLEMENT

Control

500 mL (250 mL; 2 times/day) of placebo drink for 12 weeks

DIETARY_SUPPLEMENT

100% Florida OJ

500 mL (250 mL; 2 times/day) of 100% Florida OJ for 12 weeks

DIETARY_SUPPLEMENT

100% Florida OJ-enriched

500 mL (250 mL; 2 times/day) of 100% Florida OJ-enriched for 12 weeks

Sponsors & Collaborators

  • Florida Department of Citrus

    collaborator OTHER

  • Technological Centre of Nutrition and Health

    collaborator OTHER

  • Hospital Universitari Sant Joan de Reus

    collaborator OTHER

  • University Rovira i Virgili

    collaborator OTHER

  • Technological Centre of Nutrition and Health, Spain

    lead OTHER

Principal Investigators

  • Rosa Solà Alberich, Prof, MD · • University Rovira i Virgili / Hospital Universitari Sant Joan de Reus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-12
Primary Completion
2017-07-06
Completion
2017-07-06

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479568 on ClinicalTrials.gov